Jun 24, 2025, 20:58
Saving Lives with Guidelines? ISTH 2025: Prophylactic Anticoagulation Reduces VTE by 60% and Mortality by 56%
Marc Carrier posted on X:
”Implementation matters! A guideline-driven VTE prevention program (Vermont Model) led to ~60% of high-risk cancer patients receiving prophylactic anticoagulation—resulting in a 60% reduction in VTE and 56% reduction in death. ISTH 2025, VTE Prevention”
ISTH 2025 is full of surprises we didn’t know we needed. Turns out, guidelines bring common sense to life—eventually!
Marc Carrier, MD, MSc, FRCPC, urges us to adopt the Vermont Model for prophylactic anticoagulation, in pursuit of grand reductions in VTE and death among high-risk cancer patients.
To stay updated on the world of thrombosis, be sure to subscribe to Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership